Announcements Trials

Browse Landscape

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lymphoma, Non-Hodgkin 5 Breast Neoplasms 5 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Ovarian Neoplasms 4 Lymphoma, T-Cell, Cutaneous 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Hodgkin Disease 4 Hematologic Neoplasms 4 Waldenstrom Macroglobulinemia 3 Myelodysplastic Syndromes 3 Mycosis Fungoides 3 Lymphoma, T-Cell 3 Lymphoma, Mantle-Cell 3 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Urinary Bladder Neoplasms 2 Thyroid Neoplasms 2 Sezary Syndrome 2 Sarcoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Parathyroid Neoplasms 2 Otorhinolaryngologic Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Mixed Tumor, Mesodermal 2 Mesothelioma, Cystic 2

Interventions

pembrolizumab 26 Nivolumab 18 enfortumab vedotin 7 avelumab 6 atezolizumab 6 Ipilimumab 6 Magnetic Resonance Spectroscopy 5 fludarabine 4 cabozantinib 4 Gemcitabine 4 Cyclophosphamide 4 Carboplatin 4 Specimen Handling 3 Interleukin-2 3 Docetaxel 3 130-nm albumin-bound paclitaxel 3 aldesleukin 2 Platinum 2 Pemetrexed 2 Paclitaxel 2 Oxaliplatin 2 Immunoglobulin G 2 Fluorodeoxyglucose F18 2 FAPI-46 2 Disulfides 2 Cisplatin 2 Albumin-Bound Paclitaxel 2 vinflunine 1 veliparib 1 valrubicin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma, Transitional Cell × belinostat × Clear all

NCT05154994 2026-05-07

RESOLVE

University of Utah

Phase 1 Active not recruiting

Carcinoma, Transitional Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡